Last reviewed 2026-06-11 · How we verify

Toxic effect of arsenic AND/OR its compounds — Treatment Landscape & Competitive Intelligence

Toxic effect of arsenic AND/OR its compounds (disease) competitive landscape: 1 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

Marketed treatment landscape

Approved drugs treating Toxic effect of arsenic AND/OR its compounds, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

1. Provepharm Sas · 1 drug in Toxic effect of arsenic AND/OR its compounds

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Toxic effect of arsenic AND/OR its compounds:

• Toxic effect of arsenic AND/OR its compounds treatment updates — RSS
• Toxic effect of arsenic AND/OR its compounds treatment updates — Atom
• Toxic effect of arsenic AND/OR its compounds treatment updates — JSON

Cite this brief

Drug Landscape (2026). Toxic effect of arsenic AND/OR its compounds — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/toxic-effect-of-arsenic-and-or-its-compounds. Accessed 2026-06-11.

Related

• Toxic effect of arsenic AND/OR its compounds full disease profile — treatment pathway, diagnostics, guidelines
• Browse all CI briefs
• Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing